HEALTHSTORY 618· JUNE 26, 2026

Delphia Therapeutics Names David Kerstein as Chief Medical Officer

Delphia Therapeutics has appointed David Kerstein as its chief medical officer. Kerstein arrives with direct experience in the role, having previously served as CMO at both IDRx and Theseus Pharmaceuticals — a track record that matters in…

NDNewsDialy Desk1 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 617Democratic Senators Push FCC to Freeze Paramount-Warner Bros Discovery Merger on Foreign Ownership Grounds NEXT STORY 619 →Four Ethereum Early Adopters Cash Out 37,602 ETH, Walking Away With $27M After $150M Peak Evaporated

Keep reading

More from the desk.

11HEALTH

Teresa Nunes joins EpilepsyGTx as chief medical officer

A chief medical officer (the executive who owns a company's clinical strategy and translates scientific findings into decisions the broader organization can act on) has taken a new position. Teresa Nunes, who held that title at Allucent…

health1 MIN

16HEALTH

Senate contempt vote against Anthony Fauci diverts attention from China's documented obstruction of Covid-19 data

A Senate committee voted last week to hold Anthony Fauci in contempt of Congress after he invoked the Fifth Amendment, the constitutional protection against self-incrimination, during hearin

health2 MIN

36HEALTH

FDA clears Replimune's melanoma drug Tudriqev after two rejections

A cancer treatment rejected twice by federal regulators has now won approval. The Food and Drug Administration granted accelerated approval to Tudriqev, a drug made by the biotech company Replimune, for patients with advanced melanoma…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk